AAAAAA

   
Results: 1-25 | 26-50 | 51-65
Results: 1-25/65
LACK OF EFFICACY OF RECOMBINANT HUMAN INTERLEUKIN-6 IN PATIENTS WITH ADVANCED RENAL-CELL CANCER - RESULTS OF A PHASE-II STUDY
Authors: SCHULER M BRUNTSCH U SPATHSCHWALBE E SCHREZENMEIER H PESCHEL C FARBER L BURGER KJ LEISSNER J HUBER C AULITZKY WE
Citation: M. Schuler et al., LACK OF EFFICACY OF RECOMBINANT HUMAN INTERLEUKIN-6 IN PATIENTS WITH ADVANCED RENAL-CELL CANCER - RESULTS OF A PHASE-II STUDY, European journal of cancer, 34(5), 1998, pp. 754-756
MODELING OF REACTIVE SYNTHESIS IN CONSOLIDATED BLENDS OF FINE NI AND AL POWDERS
Authors: FARBER L KLINGER L GOTMAN I
Citation: L. Farber et al., MODELING OF REACTIVE SYNTHESIS IN CONSOLIDATED BLENDS OF FINE NI AND AL POWDERS, Materials science & engineering. A, Structural materials: properties, microstructure and processing, 254(1-2), 1998, pp. 155-165
SOLID-STATE SYNTHESIS OF NIAL-NB COMPOSITES FROM FINE ELEMENTAL POWDERS
Authors: FARBER L GOTMAN I GUTMANAS EY LAWLEY A
Citation: L. Farber et al., SOLID-STATE SYNTHESIS OF NIAL-NB COMPOSITES FROM FINE ELEMENTAL POWDERS, Materials science & engineering. A, Structural materials: properties, microstructure and processing, 244(1), 1998, pp. 97-102
RECOMBINANT HUMAN GRANULOCYTE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (G-CSF AND GM-CSF) ADMINISTERED FOLLOWING CYTOTOXIC CHEMOTHERAPY HAVE A SIMILAR ABILITY TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS
Authors: HOHAUS S MARTIN H WASSMANN B EGERER G HAUS U FARBER L BURGER KJ GOLDSCHMIDT H HOELZER D HAAS R
Citation: S. Hohaus et al., RECOMBINANT HUMAN GRANULOCYTE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (G-CSF AND GM-CSF) ADMINISTERED FOLLOWING CYTOTOXIC CHEMOTHERAPY HAVE A SIMILAR ABILITY TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS, Bone marrow transplantation, 22(7), 1998, pp. 625-630
RANDOMIZED PHASE-III STUDY OF INTERLEUKIN-3 (RHIL-3) AS ADJUVANT TO IEV-CHEMOTHERAPY FOR RELAPSING AGGRESSIVE LYMPHOMAS
Authors: GERHARTZ HH MANDELLI F PHILIP T TURA S HEINZ R GREIL R SENN HJ HUBER C BLAU W FARBER L SKLENAR I HAUS U
Citation: Hh. Gerhartz et al., RANDOMIZED PHASE-III STUDY OF INTERLEUKIN-3 (RHIL-3) AS ADJUVANT TO IEV-CHEMOTHERAPY FOR RELAPSING AGGRESSIVE LYMPHOMAS, Bone marrow transplantation, 22, 1998, pp. 11-11
FORMATION OF NI5AL3 IN NI-AL LAMINATED STRUCTURES AND POWDER BLENDS
Authors: FARBER L GOTMAN I GUTMANAS EY
Citation: L. Farber et al., FORMATION OF NI5AL3 IN NI-AL LAMINATED STRUCTURES AND POWDER BLENDS, Materials letters, 34(3-6), 1998, pp. 226-231
A DIAGNOSTIC-AID FOR DETECTING (DSM-IV) MENTAL-DISORDERS IN PRIMARY-CARE
Authors: WEISSMAN MM BROADHEAD WE OLFSON M SHEEHAN DV HOVEN C CONOLLY P FIREMAN BH FARBER L BLACKLOW RS HIGGINS ES LEON AC
Citation: Mm. Weissman et al., A DIAGNOSTIC-AID FOR DETECTING (DSM-IV) MENTAL-DISORDERS IN PRIMARY-CARE, General hospital psychiatry, 20(1), 1998, pp. 1-11
DISLOCATIONS AND STACKING-FAULTS IN TI3SIC2
Authors: FARBER L BARSOUM MW ZAVALIANGOS A ELRAGHY T LEVIN I
Citation: L. Farber et al., DISLOCATIONS AND STACKING-FAULTS IN TI3SIC2, Journal of the American Ceramic Society, 81(6), 1998, pp. 1677-1681
TREATMENT INTENSIFICATION WITH INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH SMALL-CELL LUNG-CANCER
Authors: GATZEMEIER U VONPAWEL J TISCHERNEUHAUS R HAUS U FARBER L
Citation: U. Gatzemeier et al., TREATMENT INTENSIFICATION WITH INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH SMALL-CELL LUNG-CANCER, European journal of cancer, 33, 1997, pp. 1095-1095
GENE AD CELLULAR THERAPY AT NOVARTIS-PHARMA
Authors: BURGER KJ HAUS U FARBER L
Citation: Kj. Burger et al., GENE AD CELLULAR THERAPY AT NOVARTIS-PHARMA, European journal of cancer, 33, 1997, pp. 112-112
THE EFFECT OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER CHEMOTHERAPY OF VARIOUS TUMORS
Authors: HAUS U FARBER L ULLRICH S BURGER KJ
Citation: U. Haus et al., THE EFFECT OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER CHEMOTHERAPY OF VARIOUS TUMORS, Anti-cancer drugs, 8(6), 1997, pp. 597-602
TREATMENT OF PROLONGED CHEMOTHERAPY-INDUCED SEVERE THROMBOCYTOPENIA WITH RECOMBINANT HUMAN INTERLEUKIN-3 - A REPORT ON 4 CASES
Authors: FARBER L HAUS U FUCHSEL G THEML H CHATSIPROIOS D SCHMID H BURGER KJ DRECHSLER S
Citation: L. Farber et al., TREATMENT OF PROLONGED CHEMOTHERAPY-INDUCED SEVERE THROMBOCYTOPENIA WITH RECOMBINANT HUMAN INTERLEUKIN-3 - A REPORT ON 4 CASES, Anti-cancer drugs, 8(3), 1997, pp. 288-292
THE NATURAL-HISTORY OF LOCAL-REGIONAL BREAST-CANCER RECURRENCE - PROGNOSIS AND IMPLICATIONS FOR SYSTEMIC THERAPY
Authors: HAFFTY BG BURTNESS B PAPAC R MARSH J WARD B FARBER L REISS M
Citation: Bg. Haffty et al., THE NATURAL-HISTORY OF LOCAL-REGIONAL BREAST-CANCER RECURRENCE - PROGNOSIS AND IMPLICATIONS FOR SYSTEMIC THERAPY, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 258-258
PERIPHERAL-BLOOD STEM CELL (PBSC) MOBILIZATION WITH CHEMOTHERAPY FOLLOWED BY SEQUENTIAL IL-3 AND G-CSF ADMINISTRATION IN EXTENSIVELY PRETREATED PATIENTS
Authors: KOLBE K PESCHEL C RUPILIUS B DESPRES D BURGER K SKLENAR I FARBER L HUBER C DERIGS HG
Citation: K. Kolbe et al., PERIPHERAL-BLOOD STEM CELL (PBSC) MOBILIZATION WITH CHEMOTHERAPY FOLLOWED BY SEQUENTIAL IL-3 AND G-CSF ADMINISTRATION IN EXTENSIVELY PRETREATED PATIENTS, Bone marrow transplantation, 20(12), 1997, pp. 1027-1032
ASSESSING PSYCHIATRIC IMPAIRMENT IN PRIMARY-CARE WITH THE SHEEHAN DISABILITY SCALE
Authors: LEON AC OLFSON M PORTERA L FARBER L SHEEHAN DV
Citation: Ac. Leon et al., ASSESSING PSYCHIATRIC IMPAIRMENT IN PRIMARY-CARE WITH THE SHEEHAN DISABILITY SCALE, International journal of psychiatry in medicine, 27(2), 1997, pp. 93-105
LONG-TERM EXPERIENCE WITH SANDIMMUN-NEORAL - RESULTS IN DE-NOVO AND STABLE RENAL-TRANSPLANT PATIENTS AFTER 24-MONTH TREATMENT
Authors: KORN A FARBER L MAIBUCHER A BUCHHOLZ B OFFERMANN G
Citation: A. Korn et al., LONG-TERM EXPERIENCE WITH SANDIMMUN-NEORAL - RESULTS IN DE-NOVO AND STABLE RENAL-TRANSPLANT PATIENTS AFTER 24-MONTH TREATMENT, Transplantation proceedings, 29(7), 1997, pp. 2945-2947
COMPARISON OF EFFICACY, SAFETY, AND TOLERABILITY OF NEORAL VS SANDIMMUN IN DE-NOVO RENAL-TRANSPLANT PATIENTS OVER 24 MONTHS TREATMENT
Authors: ABENDROTH D BUCHHOLZ B LAND W MAY G WIESEL M FARBER L KORN A MAIBUCHER A
Citation: D. Abendroth et al., COMPARISON OF EFFICACY, SAFETY, AND TOLERABILITY OF NEORAL VS SANDIMMUN IN DE-NOVO RENAL-TRANSPLANT PATIENTS OVER 24 MONTHS TREATMENT, Transplantation proceedings, 29(1-2), 1997, pp. 275-276
CYCLOSPORINE NEW ORAL FORMULATION FOR EARLY ORAL IMMUNOSUPPRESSIVE THERAPY IN LIVER-TRANSPLANT RECIPIENTS
Authors: WINKLER M HALLER GW OLDHAFER K BECHSTEIN WO MAIBUCHER A FARBER L RINGE B NEUHAUS P PICHLMAYR R
Citation: M. Winkler et al., CYCLOSPORINE NEW ORAL FORMULATION FOR EARLY ORAL IMMUNOSUPPRESSIVE THERAPY IN LIVER-TRANSPLANT RECIPIENTS, Transplantation proceedings, 29(1-2), 1997, pp. 544-546
DOWN-REGULATION OF THE PROINFLAMMATORY CYTOKINE RESPONSE TO ENDOTOXINBY PRETREATMENT WITH THE NONTOXIC LIPID-A ANALOG-SDZ-MRL-953 IN CANCER-PATIENTS
Authors: KIANI A TSCHIERSCH A GABORIAU E OTTO F SEIZ A KNOPF HP STUTZ P FARBER L HAUS U GALANOS C MERTELSMANN P ENGELHARDT R
Citation: A. Kiani et al., DOWN-REGULATION OF THE PROINFLAMMATORY CYTOKINE RESPONSE TO ENDOTOXINBY PRETREATMENT WITH THE NONTOXIC LIPID-A ANALOG-SDZ-MRL-953 IN CANCER-PATIENTS, Blood, 90(4), 1997, pp. 1673-1683
PERIPHERAL-BLOOD STEM-CELL (PBSC) MOBILIZATION WITH CHEMOTHERAPY FOLLOWED BY SEQUENTIAL IL-3 AND G-CSF ADMINISTRATION IN EXTENSIVELY PRETREATED PATIENTS
Authors: KOLBE K PESCHEL C RUPILIUS B DESPRES D BURGER K SKLENAR I FARBER L HUBER C DERIGS HG
Citation: K. Kolbe et al., PERIPHERAL-BLOOD STEM-CELL (PBSC) MOBILIZATION WITH CHEMOTHERAPY FOLLOWED BY SEQUENTIAL IL-3 AND G-CSF ADMINISTRATION IN EXTENSIVELY PRETREATED PATIENTS, Blood, 90(10), 1997, pp. 4225-4225
RECOMBINANT HUMAN GM-CSF OR RECOMBINANT HUMAN G-CSF FOR THE MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS - RESULTS OF A PROSPECTVE RANDOMIZED STUDY
Authors: HOHAUS S MARTIN H GOLDSCHMIDT H HAUS U FARBER L BURGER KJ HOELZER D HAAS R
Citation: S. Hohaus et al., RECOMBINANT HUMAN GM-CSF OR RECOMBINANT HUMAN G-CSF FOR THE MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS - RESULTS OF A PROSPECTVE RANDOMIZED STUDY, Blood, 90(10), 1997, pp. 432-432
RANDOMIZED COMPARISON OF COPP ABVD VS. DOSE-ESCALATED AND TIME-ESCALATED COPP/ABVD WITH GM-CSF SUPPORT FOR ADVANCED HODGKINS-DISEASE/
Authors: GERHARTZ HH SCHWENKE H BAZARBASHI S THIEL E BLAU W HUHN D HEIMPEL H BROWN P SCHLIEMOK G ILLIGER HJ WALTHER J WILMANNS W CHARISSE G FARBER L HAUS U
Citation: Hh. Gerhartz et al., RANDOMIZED COMPARISON OF COPP ABVD VS. DOSE-ESCALATED AND TIME-ESCALATED COPP/ABVD WITH GM-CSF SUPPORT FOR ADVANCED HODGKINS-DISEASE/, Blood, 90(10), 1997, pp. 1731-1731
MENTAL-DISORDERS AND DISABILITY AMONG PATIENTS IN A PRIMARY-CARE GROUP-PRACTICE
Authors: OLFSON M FIREMAN B WEISSMAN MM LEON AC SHEEHAN DV KATHOL RG HOVEN C FARBER L
Citation: M. Olfson et al., MENTAL-DISORDERS AND DISABILITY AMONG PATIENTS IN A PRIMARY-CARE GROUP-PRACTICE, The American journal of psychiatry, 154(12), 1997, pp. 1734-1740
FALSE-POSITIVE RESULTS - A CHALLENGE FOR PSYCHIATRIC SCREENING IN PRIMARY-CARE
Authors: LEON AC PORTERA L OLFSON M WEISSMAN MM KATHOL RG FARBER L SHEEHAN DV PLEIL AM
Citation: Ac. Leon et al., FALSE-POSITIVE RESULTS - A CHALLENGE FOR PSYCHIATRIC SCREENING IN PRIMARY-CARE, The American journal of psychiatry, 154(10), 1997, pp. 1462-1464
LOW-DOSE (1.25 MG KG) CYCLOSPORINE-A - TREATMENT OF PSORIASIS AND INVESTIGATION OF THE INFLUENCE ON LIPID PROFILE/
Authors: MEFFERT H BRAUTIGAM M FARBER L WEIDINGER G
Citation: H. Meffert et al., LOW-DOSE (1.25 MG KG) CYCLOSPORINE-A - TREATMENT OF PSORIASIS AND INVESTIGATION OF THE INFLUENCE ON LIPID PROFILE/, Acta dermato-venereologica, 77(2), 1997, pp. 137-141
Risultati: 1-25 | 26-50 | 51-65